Because TRT is known to cause water retention, caution with testosterone use in patients with chronic renal insufficiency is often advised. It has also been shown that TRT may improve hepatic function in patients with end-stage liver disease. However, a small prospective study representing a cohort of cirrhotic patients demonstrated topical gels to be safe and efficacious. The majority of reports of liver toxicity and jaundice are limited to orally-administered alkylated forms of testosterone. Today, current literature suggests that TRT has a neutral to beneficial effect on reported cardiovascular events.47,48 Because some men may have a limited cardiovascular capacity, clinicians prescribing TRT must be cautious with respect to its ability to cause edema. If patients starting TRT already carry a diagnosis of OSA, physicians should counsel these patients that TRT may worsen their symptoms. Once you start TRT, you’ll have regular appointments with your healthcare provider and routine blood tests. Your body will take some time to restart production of testosterone naturally. If you stop TRT, you’ll return to your normal level of testosterone. Your healthcare provider will recommend regular testing to make sure TRT isn’t hurting your health. Your healthcare provider will work with you to figure out which option is best for you. If you stop taking testosterone, your body will have to recover its ability to make testosterone again. Part of this may be due to the difficulty defining "normal" testosterone levels and "normal" behavior. When testosterone levels rise too high, the brain sends signals to the pituitary to reduce production. What's more, testosterone plays other important roles in health and disease that may surprise you. Although IPSS scores were shown to significantly improve with TRT over the first 5 years of therapy, one might postulate that if prostate volume continues to increase with continued use of TRT, then LUTS may subsequently worsen after a period of improvement. To date, there are no other long-term studies that have adequately evaluated the potential risk of erythrocytosis from TRT. It is recommended that clinicians inquire about symptoms of OSA in men with TD on TRT and to offer a referral for polysomnogram evaluation in men with hallmark symptoms, especially those who are starting T therapy Bhasin et al. 2010. This trial concluded that 18 weeks of TRT improved several important cardiometabolic parameters, including insulin resistance, decreased liver fat, and increased lean muscle mass, but did not differentially reduce overall weight or the metabolic syndrome. The potential risk of adverse effects of TRT on sleep, specifically OSA, has been a growing area of research and discussion. While this study also demonstrates the desired effect of decreasing prostate volume, it failed to demonstrate any significant improvement in symptom scores or objective measures of urinary function. A prospective study of 120 men with TD receiving TRT observed that men who experienced improvement in symptoms had significantly higher baseline American Urological Association Symptom Index (AUASI) scores than those who experienced no change or interval worsening in symptoms Pearl et al. 2013. If a man's testosterone is below the normal range, it's best to repeat it once more to be sure before starting testosterone therapy - often staying on it indefinitely. Many experts argue the PSA test is not very reliable because men with a high PSA level may not have cancer and some men with cancer have a normal PSA result. In a draft recommendation last year, it said no to population-wide screening using the prostate specific antigen (PSA) test, saying it "is likely to cause more harm than good". "These skin patches are more convenient and less invasive and could give men greater choice in their treatment based on what’s important to them and how they live their lives." Testosterone replacement therapy can improve many of the symptoms of low testosterone (male hypogonadism). Certain existing health conditions make it unsafe, like prostate cancer and heart failure. Testosterone replacement therapy (TRT) can help improve the symptoms of low testosterone due to male hypogonadism. TESTOSTERONE (tes TOS ter one) is used to increase testosterone levels in your body. Testosterone injections increase your testosterone levels. Some men and women experience immediate side effects of testosterone treatment, such as acne, disturbed breathing while sleeping, breast swelling or tenderness, or swelling in the ankles. However, many men with normal testosterone levels have similar symptoms, so a direct connection between testosterone levels and symptoms is not always clear. • In men, the goal is physiologic replacement with symptom benefit, not maximal lab values. In general, guidelines aim for symptom improvement within the normal physiologic male range rather than supraphysiologic levels (Bhasin et al., Journal of Clinical Endocrinology & Metabolism, 2018). A more personalized, proactive partnership should protect against over-treatment just as much as under-treatment. That is why good hormone care depends on more than a screenshot of a lab result. In transdermal therapy, timing matters differently. Next, this study excluded 128 hypogonadal men (originally reported as 1132, of whom over 100 were actually women) who had suffered either MI or stroke, prior to initiation of T therapy. A retrospective cohort study of men with serum T levels below 300 ng/dl who underwent coronary angiography in the Veterans Affairs (VA) healthcare system between 2005 and 2011 investigated the association between TRT and all-cause mortality, myocardial infarction (MI), and stroke in 8709 men Vigen et al. 2013. In trials not explicitly funded by the pharmaceutical industry, the risk of a cardiovascular-related event on T therapy was greater odds ratio (OR) 2.06, 95% confidence interval (CI) 1.34–3.17 compared with trials funded by the pharmaceutical industry (OR 0.89, 95% CI 0.50–1.60). TD has been identified concomitantly with many comorbid health conditions in men, including cardiovascular disease (CVD), metabolic syndrome, diabetes mellitus, hypertension, and dyslipidemia, while positing an associative relationship. Testosterone deficiency (TD) in men has garnered substantial attention over the last decade due to an increased awareness by medical providers, increased direct-to-consumer advertising in the media, and the increasing age of the male population. Just being tired isn't enough to seek testosterone replacement therapy.